Determining if there exist genetic alterations that can be associated with the diagnosis and prognosis of neuroblastic tumours, responsible for 15% of child deaths due to cancer, was the aim of the Paula Lazcoz Ripoll's PhD thesis which she recently defended at the Public University of Navarra.
